CRYSTAL BELFLOWER: Open Payments
NPI 1427567841 · PERRY, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,318 in 71 payments from 19 companies in 2025. Trend: 2023 $1,325 · 2024 $1,354 · 2025 $1,318
Food & beverage: $1,318
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $210 |
| Lilly USA, LLC | 11 | $194 |
| PFIZER INC. | 7 | $153 |
| Amgen Inc. | 12 | $148 |
| AstraZeneca Pharmaceuticals LP | 6 | $105 |
| Dexcom, Inc. | 4 | $89 |
| ABBVIE INC. | 4 | $87 |
| Astellas Pharma US Inc | 2 | $43 |
| Otsuka America Pharmaceutical, Inc. | 2 | $40 |
| Antares Pharma, Inc. | 2 | $40 |
Products named: JARDIANCE, Ozempic, NURTEC ODT, OTEZLA, Wegovy, Dexcom G6 Transmitter, EVENITY, MOUNJARO.
Industry payments across GA — which companies pay providers there.
